Abstract
Data collected from hematopoietic SCT (HSCT) centers are becoming more abundant and complex owing to the formation of organized registries and incorporation of biological data. Typically, conventional statistical methods are used for the development of outcome prediction models and risk scores. However, these analyses carry inherent properties limiting their ability to cope with large data sets with multiple variables and samples. Machine learning (ML), a field stemming from artificial intelligence, is part of a wider approach for data analysis termed data mining (DM). It enables prediction in complex data scenarios, familiar to practitioners and researchers. Technological and commercial applications are all around us, gradually entering clinical research. In the following review, we would like to expose hematologists and stem cell transplanters to the concepts, clinical applications, strengths and limitations of such methods and discuss current research in HSCT. The aim of this review is to encourage utilization of the ML and DM techniques in the field of HSCT, including prediction of transplantation outcome and donor selection.
| Original language | English |
|---|---|
| Pages (from-to) | 332-337 |
| Number of pages | 6 |
| Journal | Bone Marrow Transplantation |
| Volume | 49 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2014 |
Bibliographical note
Funding Information:This work was supported by a research grant from the Israeli Cancer Association (grant no. 20130180). Dr Roni Shouval was supported by the Dr Pinchas Borenstein Talpiot Medical Leadership Program 2013 fellowship.
Funding
This work was supported by a research grant from the Israeli Cancer Association (grant no. 20130180). Dr Roni Shouval was supported by the Dr Pinchas Borenstein Talpiot Medical Leadership Program 2013 fellowship.
| Funders | Funder number |
|---|---|
| Israeli Cancer Association | 20130180 |